Human papillomavirus infection predicts a better survival rate in patients with oropharyngeal cancer

CONCLUSIONS: Our data show that HPV infection is a predictor of better disease-free and overall survival in patients with oropharyngeal cancer. For HPV-positive oropharyngeal cancer patients weekly given cisplatin with concurrent radiotherapy can be an alternative to three weekly given cisplatin considering effectiveness and early toxicity.PMID:34522260 | PMC:PMC8425231 | DOI:10.5114/aoms.2019.83658
Source: Archives of Medical Science - Category: Biomedical Science Authors: Source Type: research